THERAPEUTIC DEVELOPMENT PLATFORM

Design the Undruggable
Validate in Silico

De-risk development with in-silico validation before spending millions on wet lab work. Every design is validated with structural confidence and mechanistic explanations.

95.7%
Target Validation AUROC
70%
Functional Coherence
1 week
vs 18 months
99.8%
Cost Reduction

Target Discovery

95.7% AUROC validation

Therapeutic Design

70% functional coherence

Structural Validation

95.8% confidence

R&D TRANSFORMATION METRICS

Transform Drug Development Economics

Every metric validated with real-world performance. De-risk development before wet lab investment with in-silico validation.

95.7%

Target Validation AUROC

Zero-shot variant impact prediction on ClinVar benchmark

Target Validation AUROC95.7/100
70%

Functional Coherence

Pfam-hit rate for generated therapeutic sequences

Functional Coherence70/100
95.8%

Structural Confidence

Average confidence for validated 3D structures

Structural Confidence95.8/100
1 week

Time to First Hit

vs 18 months traditional approach

99.8%

Cost Reduction

$2.5M → $3K per target validation

100%

Validation Pass Rate

On all validation benchmarks

Every metric validated with real-world performance. De-risk development before wet lab investment with in-silico validation.

R&D CAPABILITIES

Experience Complete R&D Platform

Click on any R&D capability below to see how CrisPRO.ai transforms therapeutic development with real-time demonstrations and validated results.

Target Discovery & Validation

Zero-shot variant impact prediction with Oracle Engine. Identifies therapeutic targets, synthetic lethal pairs, and gene essentiality with validated accuracy.

95.7% AUROC
18 months → 1 week
Click to see demo

Therapeutic Design & Generation

Generative AI with Forge Engine. Designs novel proteins, CRISPR guide RNAs, HDR repair templates, and therapeutic sequences with validated biological function.

70% functional coherence
Patent-worthy designs
Click to see demo

Structural Validation & Confirmation

3D structural validation with Boltz Engine. AlphaFold 3 integration confirms structural integrity, binding affinity, and therapeutic mechanism.

95.8% confidence
De-risk before wet lab
Click to see demo

IND Package Generation

Automated IND-ready dossier generation with complete audit trails, structural validation, and mechanistic explanations for regulatory submission.

Complete dossier
Accelerate to IND
Click to see demo

IP Monetization Workflow

Complete IP documentation workflow with design provenance, novelty validation, and patent-ready documentation for therapeutic candidates.

Patent-worthy designs
IP Protection
Click to see demo
R&D CAPABILITY TESTING

Test R&D Capabilities Live

Click on any R&D capability to see how it transforms therapeutic development with validated performance metrics and real-time demonstrations.

R&D Capability Testing Engine

Target Discovery & Validation

95.7% AUROC

Outcome: 18 months → 1 week
Test

Therapeutic Design & Generation

70% functional coherence

Outcome: Patent-worthy designs
Test

Structural Validation & Confirmation

95.8% confidence

Outcome: De-risk before wet lab
Test

IND Package Generation

Complete dossier

Outcome: Accelerate to IND
Test

IP Monetization Workflow

Patent-worthy designs

Outcome: IP Protection
Test

🔬 Experience Our R&D Capabilities

De-risk development with in-silico validation before spending millions on wet lab work. Every design is validated with structural confidence and mechanistic explanations.

Target Discovery & Validation

Zero-Shot Variant Impact

Performance
95.7% AUROC
60 seconds
API Pipeline
predict_variant_impactpredict_gene_essentialitypredict_protein_functionality_change

Experience how Target Discovery & Validation works with real-time AI-powered analysis

Powered by the World's First Biological Foundation Models

These are the AI engines that power CrisPRO R&D. Each engine provides validated technical capabilities for therapeutic design and validation.

Oracle: Discriminative AI Engine

Powered by Evo2 40B-parameter model with 1M-token context window

Core Capabilities

Variant Impact Prediction

95.7% ClinVar AUROC

95.7%
ClinVar AUROC
53,210
Samples
Gene Essentiality Analysis

0.82-0.99 AUROC range

0.82-0.99
AUROC Range
0.73
DepMap Correlation
Explore Oracle

Forge: Generative AI Engine

An agentic platform for designing cancer immunotherapies: from automated variant interpretation to in silico therapeutic validation.

Core Capabilities

Guide RNA Design

Generate CRISPR guide RNAs with minimal off-targets and maximum on-target efficiency using Evo2's genomic understanding.

92%
On-target efficiency
<0.1
Off-target score
HDR Repair Templates

Design optimized repair templates with ultra-long homology arms for precise genome editing and therapeutic corrections.

78%
HDR efficiency
4.2kb
Avg arm length
Explore Forge

⚡ Boltz: 3D Structural Assessment

3D structural validation and binding affinity prediction with AlphaFold 3 integration

Core Capabilities

3D Structural Validation

AlphaFold 3 integration for complex confidence scoring

95.8%
Average Confidence
83%
High Confidence Threshold
Binding Affinity Prediction

Therapeutic-target interaction analysis

Confirmed
3D Structures
Multi-Component
Validation
Explore Boltz

🎯 Command Center: Central Nervous System

Workflow orchestration, provenance tracking, and evidence aggregation

Core Capabilities

Pipeline Orchestration

Multi-engine workflow coordination

5-Stage
Pipeline
Real-Time
Monitoring
Provenance Tracking

Complete audit trail from input to therapeutic design

Complete
Audit Trail
Cryptographic
Verification
Explore Command Center
Loading content...

Explore Other Products